Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Surgical Endoscopy
Erschienen in: Surgical Endoscopy 1/2018

14.11.2017 | White Paper

ASGE EndoVators Summit: defining the role and value of endoscopic therapies in obesity management

verfasst von: Marvin Ryou, Kenneth R. McQuaid, Christopher C. Thompson, Steven Edmundowicz, Klaus Mergener, ASGE EndoVators Task Force

Erschienen in: Surgical Endoscopy | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

On November 20 and 21, 2016, the American Society for Gastrointestinal Endoscopy (ASGE) and the Association for Bariatric Endoscopy (ABE) hosted the EndoVators Summit at the Institute for Training and Technology in Downers Grove, Illinois to define the role and value of endoscopic therapies in obesity management. Nearly 100 obesity management experts, innovators, and key decision makers from industry, insurers, and regulatory agencies gathered to review the current state of the obesity epidemic in America and the role that endoscopic bariatric and metabolic therapies (EBMTs) could play in the management of this chronic disease. Additionally, ASGE invited leaders of societies with an interest in EBMTs to participate in an exchange of ideas related to the training, research, and education in EBMTs with the goal of identifying areas of cooperation and coordination. The following societies were represented: …
Literatur
1.
Flegal KM, Kruszon-Moran D, Carroll MD et al (2016) Trends in obesity among adults in the United States, 2005 to 2014. JAMA 315:2284–2281CrossRefPubMed
2.
3.
Ogden CL, Carroll MD, Fryar CD et al (2015) Prevalence of obesity among adults and youth: United States, 2011–2014. NCHS Data Brief 219:1–8
4.
Ogden CL, Lamb M, Carroll M et al (2010) Obesity and socioeconomic status in adults: United States, 2005–2008. NCHS Data Brief 50:1–8
5.
6.
Finkelstein E, Trogdon J, Cohen J et al (2009) Annual medical spending attributable to obesity: payer- and service-specific estimates. Health Aff 28:w822–w831CrossRef
7.
Arterburn DE, Maciejewski M, Tsevat J (2005) Impact of morbid obesity on medical expenditures in adults. Int J Obes 29:334–339CrossRef
8.
Centers for Disease Control and Prevention (CDC) (2010) Adverse childhood experiences reported by adults—five states, 2009. MMWR Morb Mortal Wkly Rep 59:1609–1613
9.
Fellitti VJ, Anda RF, Nordenberg D et al (1998) Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study. Am J Prev Med 14:245–258CrossRef
10.
Lodhia NA, Rosas U, Moore M et al (2015) Do adverse childhood experiences affect surgical weight loss outcomes? J Gastrointest Surg 19:993–998CrossRefPubMed
11.
Bray GA (2003) Obesity illustrated. In: An atlas of obesity and weight control. Parthenon Publishing, New York, p 79
12.
13.
Nielsen SJ, Popkin BM (2003) Patterns and trends in food portion sizes, 1977–1998. JAMA 189:450–453CrossRef
14.
Powell E (2014) Recent trends in added sugar intake among U.S. children and adults from 1977 to 2010. Poster abstract presented at the Obesity Society Annual Meeting at Obesity Week 2014, Boston, MA, 2–7 Nov 2014
15.
Hu FB, Lee TY, Colditz GA et al (2003) Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA 289:1785–1791CrossRefPubMed
16.
Ladabaum U, Mannalithara A, Myer PA et al (2014) Obesity, abdominal obesity, physical activity, and caloric intake in US adults: 1988 to 2010. Am J Med 127:717–727CrossRefPubMedPubMedCentral
17.
Badman MK, Flier JS (2005) The gut and energy balance: visceral allies in the obesity wars. Science 307:1909–1914CrossRefPubMed
18.
Korner J, Leibel RL (2003) To eat or not to eat—how the gut talks to the brain. N Engl J Med 349:926–928CrossRefPubMed
19.
Drucker DJ, Nauck MA (2006) The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368:1696–1705CrossRefPubMed
20.
Siegel KR, McKeever B, Imperatore G et al (2016) Association of higher consumption of foods derived from subsidized commodities with adverse cardiometabolic risk among US adults. JAMA Intern Med 176:1124–1132CrossRefPubMed
21.
Seligman HK, Schillinger D (2010) Hunger and socioeconomic disparities in chronic disease. N Engl J Med 363:6–9CrossRefPubMed
22.
Seligman HK, Laraia BA, Kushel MB (2010) Food insecurity is associated with chronic disease among low-income NHANES participants. J Nutr 140:304–310CrossRefPubMedPubMedCentral
23.
Malik VS, Hu FB (2015) Fructose and cardiometabolic health: what the evidence from sugar-sweetened beverages tells us. J Am Coll Cardiol 66:1615–1624CrossRefPubMedPubMedCentral
24.
Schillinger D, Grumbach K, Piette J et al (2002) Association of health literacy with diabetes outcomes. JAMA 288:475–482CrossRefPubMed
25.
Kushner RF (2014) Weight loss strategies for treatment of obesity. Prog Cardiovasc Dis 56:465–472CrossRefPubMed
26.
Price JH, Desmond SM, Krol RA et al (1987) Family practice physicians’ beliefs, attitudes, and practices regarding obesity. Am J Prev Med 3:339–345PubMed
27.
Hill JO, Wyatt H (2002) Outpatient management of obesity: a primary care perspective. Obes Res 10(suppl):124S–130SCrossRefPubMed
28.
Moyer VA, U.S. Preventive Services Task Force (2012) Screening for and management of obesity in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 157:378–378
29.
Lefevre ML, U.S. Preventive Services Task Force (2014) Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 161:587–593CrossRefPubMed
30.
Garvey WT, Mechanick JI, Brett EM et al (2016) American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive clinical practice guidelines for medical care of patients with obesity: executive summary. Endocr Pract 22:842–884CrossRefPubMed
31.
Rubino F, Nathan DM, Eckel RH et al (2016) Metabolic surgery in the treatment algorithm for Type 2 diabetes: a joint statement by International Diabetes Organizations. Diabetes Care 39:861–877CrossRefPubMed
32.
Jensen MD, Ryan DH, Apovian CM et al (2014) 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol 63:2985–3023CrossRefPubMed
33.
Apovian CM, Arrone LJ, Bessesen DH et al (2015) Pharmacological management of obesity: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 100:342–362CrossRefPubMed
34.
35.
36.
37.
Wadden TA, Webb VL, Moran CH et al (2012) Lifestyle modification for obesity: new developments in diet, physical activity, and behavior therapy. Circulation 125:1157–1170CrossRefPubMedPubMedCentral
38.
Look AHEAD Research Group (2013) Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 369:145–154CrossRef
39.
Dombrowski SU, Knittle K, Avenell A et al (2014) Long term maintenance of weight loss with non-surgical interventions in obese adults: systematic review and meta-analyses of randomized controlled trials. BMJ 348:g2646CrossRefPubMedPubMedCentral
40.
Hamdy O, Carver C (2008) The Why WAIT program: improving clinical outcomes through weight management in type 2 diabetes. Curr Diab Rep 8:413–420CrossRefPubMed
41.
Hamdy O, Mottalib A, Morsi A et al (2017) Long-term effect of intensive lifestyle intervention on cardiovascular risk factors in patients with diabetes in real-world clinical practice: a 5-year longitudinal study. BMJ Open Diab Res Care 5(1):e000259CrossRefPubMedPubMedCentral
42.
Sjostrom L, Lindroos AK, Peltonen M et al (2004) Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351:2683–2693CrossRefPubMed
43.
Angrisani L, Santonicola A, Iovino P et al (2015) Bariatric surgery worldwide 2013. Obes Surg 25:1822–1832CrossRefPubMed
44.
Diamantis T, Apostolou KG, Alexandrou A et al (2014) Review of long-term weight loss results after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis 10:177–183CrossRefPubMed
45.
Young MT, Gebhart A, Phelan MJ et al (2015) Use and outcomes of laparoscopic sleeve gastrectomy vs laparoscopic gastric bypass: analysis of the American College of Surgeons NSQIP. J Am Coll Surg 220:880–885CrossRefPubMed
46.
Schauer PR, Bhatt DL, Kirwan JP et al (2014) Bariatric surgery versus intensive medical therapy for diabetes—3 year outcomes. N Engl J Med 370:2002–2013CrossRefPubMedPubMedCentral
47.
National Institute for Health and Care Excellence (2014) Obesity: identification, assessment and management of overweight and obesity in children, young people and adults: partial update of CG43. National Clinical Guideline Centre, London
48.
Cohen R, Pinheiro JC, Schiavon CA et al (2012) Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diab Care 35:1420–1428CrossRef
49.
Dixon JB, O’Brien PE, Playfair J et al (2008) Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 299:316–323PubMed
50.
ASGE Bariatric Endoscopy Task Force and ASGE Technology Committee, Abu Dayyeh BK, Kumar N, Edmundowicz SA et al (2015) ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc 82:425–438CrossRef
51.
Ginsberg GG, Chand B, Cote GA et al (2011) A pathway to endoscopic bariatric therapies. Gastrointest Endosc 74:943–953CrossRefPubMed
52.
ASGE/ASMBS Task Force on Endoscopic Bariatric Therapy (2011) A pathway to endoscopic bariatric therapies. Surg Obes Relat Dis 7:672–682CrossRef
53.
Ponce J, Woodman G, Swain J et al (2015) The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity. Surg Obes Relat Dis 11:874–881CrossRefPubMed
54.
Sullivan S, Swain JM, Woodman G et al (2016) The Obalon swallowable 6-month balloon system is more effective than moderate intensity lifestyle therapy alone: results from a 6-month randomized sham controlled trial. Gastroenterology 150(4 suppl 1):S126
55.
Thompson CC, Abu Dayyeh BK, Kushner R et al (2017) Percutaneous gastrostomy device for the treatment of class II and class III obesity: results of a randomized controlled trial. Am J Gastroenterol 112:447CrossRefPubMed
56.
Lopez-Nava G, Sharaiha RZ, Galvao Neto M et al (2016) Endoscopic sleeve gastroplasty for obesity: a multicenter study of 242 patients with 18 months follow-up. Gastroenterology 150(4 suppl 1):S26CrossRef
57.
Sullivan S, Swain JM, Woodman G et al (2017) Randomized sham-controlled trial evaluating efficacy and safety of endoscopic gastric plication for primary obesity: the ESSENTIAL trial. Obesity 25:294–301CrossRefPubMed
58.
Mingrone G, Panuzi S, De Gaetano A et al (2012) Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 366:1577–1585CrossRefPubMed
59.
Schauer PR, Bhatt DL, Kirwan JP et al (2017) Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes. N Engl J Med 376:641–651CrossRefPubMedPubMedCentral
60.
Nauck M, Stockmann F, Ebert R et al (1986) Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. Diabetologia 29:46–52CrossRefPubMed
61.
Rodriguez L, Reyes E, Fagalde P et al (2009) Pilot clinical study of an endoscopic, removable duodenal-jejunal bypass liner for the treatment of type 2 diabetes. Diabetes Technol Ther 11:725–732CrossRefPubMed
62.
Koehestanie P, de Jonge C, Berends FJ et al (2014) The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial. Ann Surg 260:984–992CrossRefPubMed
63.
Rajagopalan H, Cherington AD, Thompson CC et al (2016) Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes: 6-month interim analysis from the first-in-human proof-of-concept study. Diabetes Care 39:2254–2261CrossRefPubMed
64.
Machytka E, Buzga M, Ryou M et al (2016) Endoscopic dual-path enteral bypass using a magnetic incisionless anastomosis system (IAS). [abstract] Gastrointest Endosc 83:AB196CrossRef
65.
Daniel S, Soleymani T, Garvey WT (2013) A complications-based clinical staging of obesity to guide treatment modality and intensity. Curr Opin Endocrinol Diabetes Obes 20:377–388CrossRefPubMedPubMedCentral
66.
MacLean PS, Wing RR, Davidson T et al (2015) NIH working group report: innovative research to improve maintenance of weight loss. Obesity 23:7–15CrossRefPubMed
Metadaten
Titel
ASGE EndoVators Summit: defining the role and value of endoscopic therapies in obesity management
verfasst von
Marvin Ryou
Kenneth R. McQuaid
Christopher C. Thompson
Steven Edmundowicz
Klaus Mergener
ASGE EndoVators Task Force
Publikationsdatum
14.11.2017
Verlag
Springer US
Erschienen in
Surgical Endoscopy / Ausgabe 1/2018
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-017-5934-x

Weitere Artikel der Ausgabe 1/2018

Surgical Endoscopy 1/2018 Zur Ausgabe

OriginalPaper

Routine versus selective upper gastrointestinal contrast series after omental patch repair for gastric or duodenal perforation

OriginalPaper

Open versus laparoscopic rectal cancer resection and risk of subsequent incisional hernia repair and paracolostomy hernia repair: a nationwide population-based cohort study

OriginalPaper

Risk factors for prolonged postoperative ileus after laparoscopic sphincter-saving total mesorectal excision for rectal cancer: an analysis of 428 consecutive patients

Video

Totally laparoscopic living donor left hepatectomy for liver transplantation in a child

OriginalPaper

Characteristics predicting laparoscopic skill in medical students: nine years’ experience in a single center

OriginalPaper

Simulation-based mastery learning for endoscopy using the endoscopy training system: a strategy to improve endoscopic skills and prepare for the fundamentals of endoscopic surgery (FES) manual skills exam

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.